Facebook sidelines contested Merck profile page

November 29, 2011
Facebook will sideline a Merck page at the social network until a pair of US and German companies work out which one gets the online address, a source familiar with the matter told AFP.

Facebook will sideline a Merck page at the social network until a pair of US and German companies work out which one gets the online address, a source familiar with the matter told AFP.

German pharmaceutical and chemical firm Merck KGaA last week called for answers from California-based Facebook after losing control of the www.facebook.com/Merck page at the leading social network.

The group was "very surprised" to discover that its Facebook page contained information on a similarly named US company, according to Merck KGaA spokesman Gangolf Schrimpf.

"The transfer of the vanity URL Facebook.com/Merck from Merck KGaA to Merck & Co. was due to an administrative error," Facebook told AFP on Monday. "We apologize for any inconvenience this may have caused."

Merck KGaA has lodged a complaint with the Supreme Court of the State of New York setting out its intention to take legal action against Facebook.

"Because Facebook is an important marketing device, the page is of great value to Merck and its misappropriation is causing harm," said the complaint.

The Merck Facebook page will be unavailable until the vying companies agree which should get it, the source told AFP.

Both Mercks are free to create new Facebook pages titled in ways that reflect the names of the companies.

In March, 2010, the German firm signed a deal with for exclusive rights to the page but was astonished to find in October this year that it had lost administrative control and page content related to US competitor .

The two firms are distantly related, but have been legally separate entities since the 1919 Treaty of Versailles after World War I when the group was split in two as part of a reparations package against Germany.

Explore further: Merck's Vioxx cases drag on

Related Stories

Merck's Vioxx cases drag on

August 21, 2007

Lawsuits related to the painkiller Vioxx have little prospect of resolution for the thousands who have sued the drug company Merck, it was reported.

Merck says US rejects its MS drug

March 2, 2011

German pharmaceutical group Merck KgaA said Wednesday that the US Food and Drug Administration (FDA) has refused to approve use of its multiple sclerosis treatment Cladribine.

Facebook sued for $1 billion over Intifada page

April 2, 2011

Facebook and co-founder Mark Zuckerberg have been hit with a lawsuit seeking more than $1 billion in damages over a page on the social network which called for a "Third Intifada" against Israel.

Facebook launches page for journalists

April 6, 2011

Facebook has launched a media resource page to help journalists use the social network as a reporting tool and better connect with their audience.

Recommended for you

Interactive tool lifts veil on the cost of nuclear energy

August 24, 2015

Despite the ever-changing landscape of energy economics, subject to the influence of new technologies and geopolitics, a new tool promises to root discussions about the cost of nuclear energy in hard evidence rather than ...

Smart home heating and cooling

August 28, 2015

Smart temperature-control devices—such as thermostats that learn and adjust to pre-programmed temperatures—are poised to increase comfort and save energy in homes.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.